Morten Praestegaard
Horsholm, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review.
Journal: Dermatology and therapy
Published: July 05, 2023
A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: A post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 14, 2023
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies.
Journal: Dermatology and therapy
Published: June 13, 2023
Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology.
Journal: Dermatology and therapy
Published: April 24, 2023
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 17, 2023
Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp.
Journal: Drugs in context
Published: February 17, 2023
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis.
Journal: The Journal of dermatological treatment
Published: August 29, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 26, 2022
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application.
Journal: Dermatology and therapy
Published: May 12, 2022
Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel.
Journal: Journal of drugs in dermatology : JDD
Published: March 07, 2022
Validation of the Self-Reported Psoriasis Treatment Convenience Scale (PTCS).
Journal: Dermatology and therapy
Published: August 20, 2021
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 21, 2021
Last Updated: 09/26/2026